Ramon Roozendaal

Leiden, ZH, Netherlands

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 19 publications

Antigen-specific IgG glycosylation profiles in hamsters and macaques following COVID-19 vaccination.

Antigen-specific IgG glycosylation profiles in hamsters and macaques following COVID-19 vaccination.

Journal: iScience
Published: October 21, 2025

Enhancing breadth and durability of humoral immune responses in non-human primates with an adjuvanted group 1 influenza hemagglutinin stem antigen.

Enhancing breadth and durability of humoral immune responses in non-human primates with an adjuvanted group 1 influenza hemagglutinin stem antigen.

Journal: NPJ vaccines
Published: June 08, 2023

Persistence of immunological memory as a potential correlate of long-term, vaccine-induced protection against Ebola virus disease in humans.

Persistence of immunological memory as a potential correlate of long-term, vaccine-induced protection against Ebola virus disease in humans.

Journal: Frontiers in immunology
Published: May 01, 2023

Comparative analysis of spike-specific IgG Fc glycoprofiles elicited by adenoviral, mRNA, and protein-based SARS-CoV-2 vaccines.

Comparative analysis of spike-specific IgG Fc glycoprofiles elicited by adenoviral, mRNA, and protein-based SARS-CoV-2 vaccines.

Journal: iScience
Published: March 27, 2023

Mechanistic Model Describing the Time Course of Humoral Immunity Following Ad26.COV2.S Vaccination in Non-Human Primates.

Mechanistic Model Describing the Time Course of Humoral Immunity Following Ad26.COV2.S Vaccination in Non-Human Primates.

Journal: The Journal of pharmacology and experimental therapeutics
Published: January 23, 2023

Booster vaccination with Ad26.COV2.S or an Omicron-adapted vaccine in pre-immune hamsters protects against Omicron BA.2.

Booster vaccination with Ad26.COV2.S or an Omicron-adapted vaccine in pre-immune hamsters protects against Omicron BA.2.

Journal: NPJ vaccines
Published: December 27, 2022

Bridging Animal and Human Data in Pursuit of Vaccine Licensure.

Bridging Animal and Human Data in Pursuit of Vaccine Licensure.

Journal: Vaccines
Published: July 09, 2022

Protection against Marburg Virus and Sudan Virus in NHP by an Adenovector-Based Trivalent Vaccine Regimen Is Correlated to Humoral Immune Response Levels.

Protection against Marburg Virus and Sudan Virus in NHP by an Adenovector-Based Trivalent Vaccine Regimen Is Correlated to Humoral Immune Response Levels.

Journal: Vaccines
Published: June 30, 2022

Non-human primate to human immunobridging demonstrates a protective effect of Ad26.ZEBOV, MVA-BN-Filo vaccine against Ebola.

Non-human primate to human immunobridging demonstrates a protective effect of Ad26.ZEBOV, MVA-BN-Filo vaccine against Ebola.

Journal: NPJ vaccines
Published: March 25, 2022

SARS-CoV-2 binding and neutralizing antibody levels after Ad26.COV2.S vaccination predict durable protection in rhesus macaques.

SARS-CoV-2 binding and neutralizing antibody levels after Ad26.COV2.S vaccination predict durable protection in rhesus macaques.

Journal: Nature communications
Published: February 16, 2021

Immunogenicity and efficacy of one and two doses of Ad26.COV2.S COVID vaccine in adult and aged NHP.

Immunogenicity and efficacy of one and two doses of Ad26.COV2.S COVID vaccine in adult and aged NHP.

Journal: The Journal of experimental medicine
Published: December 31, 2020

Nonhuman primate to human immunobridging to infer the protective effect of an Ebola virus vaccine candidate.

Nonhuman primate to human immunobridging to infer the protective effect of an Ebola virus vaccine candidate.

Journal: NPJ vaccines
Published: June 26, 2020
Showing 1-12 of 19

Last Updated: 09/26/2026